YACOUB, MONA-RITA
 Distribuzione geografica
Continente #
EU - Europa 2.588
NA - Nord America 2.584
AS - Asia 2.418
SA - Sud America 384
AF - Africa 42
OC - Oceania 16
Continente sconosciuto - Info sul continente non disponibili 2
AN - Antartide 1
Totale 8.035
Nazione #
US - Stati Uniti d'America 2.474
RU - Federazione Russa 1.559
SG - Singapore 978
CN - Cina 775
IT - Italia 416
BR - Brasile 315
HK - Hong Kong 254
VN - Vietnam 193
DE - Germania 142
FR - Francia 122
GB - Regno Unito 93
SE - Svezia 64
CA - Canada 61
IN - India 61
NL - Olanda 56
FI - Finlandia 34
MX - Messico 30
BD - Bangladesh 26
TR - Turchia 23
AR - Argentina 22
PL - Polonia 21
AT - Austria 19
ES - Italia 18
JP - Giappone 17
IQ - Iraq 16
AU - Australia 15
ZA - Sudafrica 15
ID - Indonesia 11
CL - Cile 10
CO - Colombia 10
EC - Ecuador 9
JO - Giordania 7
SA - Arabia Saudita 7
CH - Svizzera 6
MA - Marocco 6
MY - Malesia 6
PK - Pakistan 6
PY - Paraguay 6
DZ - Algeria 5
GR - Grecia 5
HN - Honduras 5
LT - Lituania 5
PH - Filippine 5
TN - Tunisia 5
UA - Ucraina 5
JM - Giamaica 4
KE - Kenya 4
PT - Portogallo 4
VE - Venezuela 4
IE - Irlanda 3
IL - Israele 3
PE - Perù 3
RO - Romania 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
BB - Barbados 2
BE - Belgio 2
BG - Bulgaria 2
BO - Bolivia 2
BW - Botswana 2
CZ - Repubblica Ceca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
IR - Iran 2
KG - Kirghizistan 2
KH - Cambogia 2
KR - Corea 2
KZ - Kazakistan 2
LV - Lettonia 2
NP - Nepal 2
PS - Palestinian Territory 2
SY - Repubblica araba siriana 2
TH - Thailandia 2
TW - Taiwan 2
UZ - Uzbekistan 2
AL - Albania 1
AM - Armenia 1
AO - Angola 1
AQ - Antartide 1
AZ - Azerbaigian 1
BH - Bahrain 1
BY - Bielorussia 1
CR - Costa Rica 1
EE - Estonia 1
EG - Egitto 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
LB - Libano 1
LC - Santa Lucia 1
MD - Moldavia 1
NG - Nigeria 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
SV - El Salvador 1
SX - ???statistics.table.value.countryCode.SX??? 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 8.035
Città #
Singapore 550
Moscow 347
Ashburn 317
San Jose 300
Dallas 268
Hong Kong 251
Shanghai 152
Milan 114
New York 105
Hefei 102
Beijing 93
Lauterbourg 85
Los Angeles 75
Ho Chi Minh City 63
Boardman 44
Hanoi 36
Atlanta 35
Munich 35
Rome 34
São Paulo 34
Guangzhou 29
Orem 29
Shenzhen 29
Nuremberg 28
Santa Clara 28
Cesano Boscone 23
Chennai 23
Denver 21
Helsinki 21
Amsterdam 18
Brooklyn 18
London 18
Houston 16
Lawrence 16
Mexico City 16
Montreal 16
Princeton 16
Toronto 16
Boston 15
Chicago 15
San Francisco 15
Warsaw 15
Council Bluffs 14
Stockholm 14
Tokyo 14
Biên Hòa 13
Poplar 13
Rio de Janeiro 13
Jiaxing 12
Mumbai 11
Bologna 10
Buffalo 10
Brisbane 9
City of London 9
Falkenstein 9
Frankfurt am Main 9
Lappeenranta 9
Phoenix 9
Washington 9
Wuxi 9
Ankara 8
Belo Horizonte 8
Buenos Aires 8
Calgary 8
Haiphong 8
Johannesburg 8
Manchester 8
Padova 8
St Petersburg 8
Vienna 8
Amman 7
Contagem 7
Da Nang 7
Florence 7
Cleveland 6
Curitiba 6
Milwaukee 6
Naples 6
Querétaro 6
Seattle 6
The Dalles 6
Wolfhagen 6
Athens 5
Brasília 5
Changsha 5
Cologne 5
Dhaka 5
Guayaquil 5
Hangzhou 5
Hải Dương 5
Jakarta 5
Ottawa 5
Quanzhou 5
Santiago 5
Xi'an 5
Baghdad 4
Campo Grande 4
Charleston 4
Charlotte 4
Gatchina 4
Totale 3.918
Nome #
The Dual Lens of Endoscopy and Histology in the Diagnosis and Management of Eosinophilic Gastrointestinal Disorders—A Comprehensive Review 747
Basal Serum Diamine Oxidase Levels as a Biomarker of Histamine Intolerance: A Retrospective Cohort Study 254
Heart Rate Variability in Subjects with Severe Allergic Background Undergoing COVID-19 Vaccination 209
Anti-IL-5 Pathway Agents in Eosinophilic-Associated Disorders Across the Lifespan 156
Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS): Focus on the Pathophysiological and Diagnostic Role of Viruses 150
Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life 139
Dupilumab: a delayed response in asthmatic and atopic patients treated for chronic rhinosinusitis with nasal polyps 137
Dupilumab as a potential steroid-sparing treatment for IgG4-related disease. 130
Severe asthma: One disease and multiple definitions 124
Evolving Clinical Manifestations and Symptom Clusters in Long-COVID Patients: a Comparative Analysis from April 2020 to Present 122
Interactions between Severe Allergy and Anxiety in Anti-SARS-CoV-2 Vaccinees 119
Efficacy of a rational algorithm to assess allergy risk in patients receiving the BNT162b2 vaccine 118
Chronic rhinosinusitis with nasal polyps impact in severe asthma patients: Evidences from the Severe Asthma Network Italy (SANI) registry 114
Effectiveness and safety of dupilumab in patients with chronic rhinosinusitis with nasal polyps and associated comorbidities: a multicentric prospective study in real life 113
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 111
Challenges to Vaccination against SARS-CoV-2 in Patients with Immune-Mediated Diseases 110
Diamine Oxidase Supplementation in Chronic Spontaneous Urticaria: A Randomized, Double-Blind Placebo-Controlled Study 110
Oral CorticoSteroid sparing with biologics in severe asthma: A remark of the Severe Asthma Network in Italy (SANI ) 108
Case report: Successful use of mepolizumab for immune checkpoint inhibitors–induced hypereosinophilic syndrome in two patients with solid malignancies 108
Early increase in eosinophil count may predict long-term hypereosinophilia during dupilumab treatment: a 2-year observational study 107
Allergy and dimethyl fumarate treatment in a patient with multiple sclerosis 107
Characteristics and treatment regimens across ERS SHARP severe asthma registries 107
Hypereosinophilia management in patients with type 2 chronic rhinosinusitis treated with dupilumab: preliminary results 106
A prospective study on the efficacy of dupilumab in chronic rhinosinusitis with type 2 inflammation 105
Hypersensitivity reactions to anti-SARS-CoV-2 vaccines: Basophil reactivity to excipients 105
Assessment of impairment/disability due to occupational asthma through a multidimensional approach 103
The role of skin tests with polyethylene glycol and polysorbate 80 in the vaccination campaign for COVID-19: results from an Italian multicenter survey 99
IgE response to Aed al 13 and Aed al 14 recombinant allergens from Aedes albopictus saliva in humans 93
Are atopy and eosinophilic bronchial inflammation associated with relapsing forms of chronic rhinosinusitis with nasal polyps? 93
Updated guidance regarding the risk of allergic reactions to COVID-19 vaccines and recommended evaluation and management: A GRADE assessment and international consensus approach 89
Correspondence on 'Immunogenicity and safety of anti-SARS-CoV-2 mRNA vaccines in patients with chronic inflammatory conditions and immunosuppressive therapy in a monocentric cohort' 86
Asthma caused by cyanoacrylate used in a leisure activity [2] 86
CLINICAL AND EPIDEMIOLOGICAL RELEVANCE OF ALLERGY IN SYSTEMIC LUPUS ERYTHEMATOSUS: AN OBSERVATIONAL STUDY 85
Caring with compassion during COVID-19 85
Defining a Severe Asthma Super-Responder: Findings from a Delphi Process 84
Capitolo 80: Malattie allergiche 82
Role of the chemokine receptors CXCR3 and CCR4 in human pulmonary fibrosis 82
Do environmental measures improve quality of life in mite-induced allergic rhinitis? 82
Anisakis hypersensitivity in Italy: prevalence and clinical features: a multicenter study 79
Chronic rhinosinusitis with nasal polyps: a pilot study on immunologic dysregulation and the role of sensitisation to aeroallergens 78
SIRM-SIAAIC consensus, an Italian document on management of patients at risk of hypersensitivity reactions to contrast media 77
Hypersensitivity reactions to iodinated contrast media in Italy: a retrospective study. Characteristics of patients and risk factors 76
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 75
Occupational asthma and occupational rhinitis in hairdressers 75
Drug reaction with eosinophilia and systemic symptoms (DRESS) in patients with COVID-19 74
EAACI position paper on occupational rhinitis 70
COVID-19 in Severe Asthma Network in Italy (SANI) patients: Clinical features, impact of comorbidities and treatments 69
Dupilumab Efficacy on Asthma Functional, Inflammatory, and Patient-Reported Outcomes across Different Disease Phenotypes and Severity: A Real-Life Perspective 69
Post-COVID-19 follow-up clinic: Depicting chronicity of a new disease 68
Eosinophils from Physiology to Disease: A Comprehensive Review 64
Drug induced exfoliative dermatitis: State of the art 63
Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy 62
HYPERSENSITIVITY REACTIONS TO LOW MOLECULAR WEIGHT HEPARIN IN A PREGNANT WOMAN 62
Reply to: Kow CS et al. Are severe asthma patients at higher risk of developing severe outcomes from COVID-19? 61
In vivo tests with "Tahini" sauce: new allergenic source to evaluate IgE-mediated hypersensitivity to sesame. 61
ITALIAN STUDY ON BUCKWHEAT ALLERGY: PREVALENCE AND CLINICAL FEATURES OF BUCKWHEAT-SENSITIZED PATIENTS IN ITALY 61
MEPOLIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS: A SINGLE CENTRE REAL-LIFE EXPERIENCE 59
HYPERSENSITIVITY TO RITUXIMAB: A RAPID AND SIMPLIFIED DESENSITIZATION PROTOCOL FOR PATIENTS WITH ANCA-ASSOCIATED VASCULITIS AND OTHER AUTOIMMUNE DISORDERS 58
Systemic allergic reactions induced by labile plant-food allergens: Seeking potential cofactors. A multicenter study 58
Severe Asthma Network Italy Definition of Clinical Remission in Severe Asthma: A Delphi Consensus 58
Optimal management of DRESS syndrome in course of infectious endocarditis. 57
Mild/Moderate Asthma Network in Italy (MANI): a long-term observational study 55
World Trade Center disaster: Short- and medium-term health outcome 54
Occupational rhinitis 54
IgG4-related disease and allergen-specific immunotherapy 54
Effects of sublingual immunotherapy on allergic inflammation: An update 53
Unusual presentation of a serum sickness-like reaction due to sulfonamides 53
Occupational asthma due to bethabara wood dust 52
Is itIt's it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? The importance of desensitization procedures in the monoclonal antibodies era 51
Occupational eosinophilic bronchitis 51
Pulmonary rehabilitation as evaluated by clinical trials: An overview 51
Guidelines for the use and interpretation of diagnostic methods in adult food allergy 51
Subacute cutaneous Lupus erythematosus induced by dupilumab: a novel possible association with specific pathogenetic mechanisms 51
Immune mechanisms of allergen-specific immunotherapy 50
Usefulness of basophil activation test in gluten sensitivity 50
Omega-5 gliadin anaphylaxis: An integrated diagnostic approach 49
Resuscitation fluids 49
Effects of sublingual immunotherapy on allergic inflammation 49
Incidence and characteristics of hospital-acquired pneumonia in a pulmonary rehabilitation setting 48
Usefulness of autologous serum and plasma skin tests in the diagnostic pathway of chronic idiopatic urticaria and/or autoimmune diseases and/or multiple drug allergy 47
Safety of sublingual immunotherapy started during the pollen season 47
Patients with breakthrough reactions to iodinated contrast media have low incidence of positive skin tests 47
Histamine release test correlates with disease activity in chronic spontaneous urticaria 46
Usefulness of induced sputum in investigating occupational asthma with normal responsiveness to methacholine: A case report 46
Erratum to "Guidelines for the use and interpretation of diagnostic methods in adult food allergy". [Clin Mol Allergy, 13, (2015), 27] DOI: 10.1186/s12948-015-0033-9 46
Histamine release positive test associates with disease remission in chronic spontaneous urticaria: a proof-of-concept study 45
Multiple drug hypersensivity: Insight into the underlying mechanism and correlation with autoimmune diseases 45
Proposal of a skin tests based approach for the prevention of recurrent hypersensitivity reactions to iodinated contrast media. 45
Wheat gastrointestinal hypersensitivity: a case report 44
Impairment of small airways in COPD patients with frequent exacerbations and effects of treatment with tiotropium 43
Usefulness of skin testing in preventing hypersensitivity to iodinated contrast media 43
Is it possible to continue a really effective therapy in a patient with a severe hypersensitivity drug reaction? 42
Effect of noninvasive mechanical ventilation in elderly patients with hypercapnic acute-on-chronic respiratory failure and a do-not-intubate order 41
Effectiveness of omalizumab in a patient with severe asthma and atopic dermatitis 41
Rituximab hypersensitivity in IgG4-related disease: successful desensitization in a patient with IgG4 rheumatoid factor 41
Omalizumab in elderly patients with chronic spontaneous urticaria: An Italian real-life experience 39
Evaluation of basophil activation test in suspected food hypersensitivity 35
Six-minute walk test cut-off value identifying COPD patients with physical disability: A pilot study 32
Chronic urticaria: Not only after COVID-19 vaccination 6
Management of Patients with Suspected Hypersensitivity to Chemotherapy Drugs: A Practical Approach in a Tertiary Care Setting 3
Totale 8.248
Categoria #
all - tutte 36.365
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.365


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202251 0 0 7 7 2 4 4 4 7 1 11 4
2022/2023116 35 24 9 0 2 15 7 8 3 3 4 6
2023/2024523 2 7 18 150 12 83 29 38 5 16 25 138
2024/20251.783 207 39 36 101 209 152 159 179 276 181 123 121
2025/20265.763 371 353 278 637 492 192 546 362 1.342 295 193 702
Totale 8.252